Nilson R, Penumutchu S, Pagano F, Belenky P
mSphere. 2024; 9(8):e0010324.
PMID: 39109911
PMC: 11351048.
DOI: 10.1128/msphere.00103-24.
Wielogorska E, Flynn P, Meneely J, Thompson T, Graham W, Gilmore B
Antibiotics (Basel). 2023; 12(7).
PMID: 37508211
PMC: 10376056.
DOI: 10.3390/antibiotics12071115.
Hassan F, Sher M, Hussain M, Saadia M, Naeem-Ul-Hassan M, Rehman M
ACS Omega. 2023; 7(51):48506-48519.
PMID: 36591136
PMC: 9798760.
DOI: 10.1021/acsomega.2c06662.
Lemaignen A, Bernard L, Tattevin P, Bru J, Duval X, Hoen B
BMJ Open. 2020; 10(7):e033540.
PMID: 32665381
PMC: 7365486.
DOI: 10.1136/bmjopen-2019-033540.
Sorensen C, Knudsen C, Auf dem Keller U, Kalogeropoulos K, Gutierrez-Jimenez C, Pucca M
Toxins (Basel). 2020; 12(4).
PMID: 32283690
PMC: 7232225.
DOI: 10.3390/toxins12040240.
Pig liver esterases PLE1 and PLE6: heterologous expression, hydrolysis of common antibiotics and pharmacological consequences.
Zhou Q, Xiao Q, Zhang Y, Wang X, Xiao Y, Shi D
Sci Rep. 2019; 9(1):15564.
PMID: 31664043
PMC: 6820543.
DOI: 10.1038/s41598-019-51580-4.
Treatment of Ampicillin-Resistant Urinary Tract Infections.
Richey E, Waters P, Jovic M, Rakhman C
Fed Pract. 2019; 32(6):20-23.
PMID: 30766068
PMC: 6363309.
Community Composition Determines Activity of Antibiotics against Multispecies Biofilms.
Tavernier S, Crabbe A, Hacioglu M, Stuer L, Henry S, Rigole P
Antimicrob Agents Chemother. 2017; 61(9).
PMID: 28696232
PMC: 5571329.
DOI: 10.1128/AAC.00302-17.
Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.
Sharma B, Brown A, Matluck N, Hu L, Lewis K
Antimicrob Agents Chemother. 2015; 59(8):4616-24.
PMID: 26014929
PMC: 4505243.
DOI: 10.1128/AAC.00864-15.
Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review.
Al-Omari A, Cameron D, Lee C, Corrales-Medina V
BMC Infect Dis. 2014; 14:140.
PMID: 24624933
PMC: 4007569.
DOI: 10.1186/1471-2334-14-140.
The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics.
van Hasselt J, Andrew M, Hebert M, Tarning J, Vicini P, Mattison D
Br J Clin Pharmacol. 2012; 74(6):932-9.
PMID: 22452385
PMC: 3522806.
DOI: 10.1111/j.1365-2125.2012.04280.x.
Variations in amoxicillin pharmacokinetic/pharmacodynamic parameters may explain treatment failures in acute otitis media.
E Pichichero M, Reed M
Paediatr Drugs. 2009; 11(4):243-9.
PMID: 19566108
DOI: 10.2165/00148581-200911040-00003.
Effect of betamethasone and diclofenac sodium on serum and tissue concentration of amoxicillin. In vivo study in rats.
Mattos Filho T, Junqueira M, Groppo F, Motta R, Perazzo F
J Appl Oral Sci. 2008; 14(5):319-23.
PMID: 19089051
PMC: 4327221.
DOI: 10.1590/s1678-77572006000500004.
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
Subramanian S, Roberts C, Hart C, Martin H, Edwards S, Rhodes J
Antimicrob Agents Chemother. 2007; 52(2):427-34.
PMID: 18070962
PMC: 2224732.
DOI: 10.1128/AAC.00375-07.
Triple crossover study on absorption and excretion of ampicillin, pivampicillin, and amoxycillin.
Verbist L
Antimicrob Agents Chemother. 1974; 6(5):588-93.
PMID: 15825310
PMC: 444697.
DOI: 10.1128/AAC.6.5.588.
Pharmacokinetics and efficacy of linezolid in a gerbil model of Streptococcus pneumoniae-induced acute otitis media.
Humphrey W, Shattuck M, Zielinski R, Kuo M, Biermacher J, Smith D
Antimicrob Agents Chemother. 2003; 47(4):1355-63.
PMID: 12654670
PMC: 152499.
DOI: 10.1128/AAC.47.4.1355-1363.2003.
In vitro activity of clarithromycin against intracellular Helicobacter pylori.
Piccolomini R, Di Bonaventura G, Picciani C, Laterza F, Vecchiet J, Neri M
Antimicrob Agents Chemother. 2001; 45(5):1568-71.
PMID: 11302831
PMC: 90509.
DOI: 10.1128/AAC.45.5.1568-1571.2001.
New pharmacokinetic in vitro model for studies of antibiotic activity against intracellular microorganisms.
Hulten K, Rigo R, Gustafsson I, Engstrand L
Antimicrob Agents Chemother. 1996; 40(12):2727-31.
PMID: 9124830
PMC: 163611.
DOI: 10.1128/AAC.40.12.2727.
Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid.
Fuchs P, Barry A
J Clin Microbiol. 1994; 32(11):2846-50.
PMID: 7852584
PMC: 264172.
DOI: 10.1128/jcm.32.11.2846-2850.1994.
A comparison of the pharmacokinetics of bacampicillin, ampicillin, amoxicillin, and cyclacillin: oral administration in infants and children.
McCracken Jr G
Bull N Y Acad Med. 1983; 59(5):468-76.
PMID: 6576831
PMC: 1911665.